Proton therapy is a type of radiation therapy. It USES a 200-ton device to shoot high-energy particles at the speed of about 2/3 of the speed of light to destroy tumor cells and rarely damage normal human tissues.The technique was first used in patients in the 1950s and perfected in the late 1970s.
In recent years, with the increasingly mature technology, proton therapy has been accepted by more and more patients in many countries and countries in the world
The district is actively preparing to construct and strive to construct proton therapy center.
Proton therapy devices in the world are mainly concentrated in the United States, Japan, Europe and other regions.Affected by the purchase cost and maintenance cost, the main consumption areas are also concentrated in these areas. In addition, the application scope of proton therapy is gradually expanded. There are proton therapy centers in Australia, mainland China, South Korea, Taiwan and South Africa.
Proton therapy instrument manufacturers have obvious concentration, high threshold, and very high technical and capital requirements. The whole market is mainly dominated by IBA and varian, among which IBA alone has a cumulative market share of nearly 50%.In the future, with miniaturization and price reduction, the concentration of manufacturers is expected to gradually reduce.
In terms of technology, the major proton accelerators are cyclotron and synchrotron, among which the share of synchrotron is gradually increasing.
The development prospect of the whole proton therapy instrument industry is broad, and the global order growth is obvious. In particular, a large number of hospitals or units with intention to build proton therapy centers have emerged in China in recent years, providing a large development space for manufacturers who intend to enter the field of proton therapy

Market Analysis and Insights: Global Proton Therapy Instrument Market
The global Proton Therapy Instrument market is valued at US$ 757.8 million in 2019. The market size will reach US$ 966.8 million by the end of 2026, growing at a CAGR of 3.5% during 2021-2026.

Global Proton Therapy Instrument Scope and Segment
Proton Therapy Instrument market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Proton Therapy Instrument market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Synchrotron
Cyclotron
Synchrocyclotron
Linear accelerator

Segment by Application
Hosptial
Proton Treatment Center

By Company
BA
Varian
Hitachi
Mevion
Sumitomo
ProNova

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E